| BSE: 524494 | Sector: Health care |
| NSE: IPCALAB | ISIN Code: INE571A01020 |
| BSE 00:00 | 15 Feb | 775.00 |
18.45 (2.44%) |
OPEN
757.00 |
HIGH
779.00 |
LOW
750.05 |
| NSE 00:00 | 15 Feb | 775.35 |
18.50 (2.44%) |
OPEN
757.00 |
HIGH
779.85 |
LOW
750.00 |
| OPEN | 757.00 |
| PREVIOUS CLOSE | 756.55 |
| VOLUME | 3563 |
| 52-Week high | 823.50 |
| 52-Week low | 590.10 |
| P/E | 24.68 |
| Mkt Cap.(Rs cr) | 9,792 |
| Buy Price | 770.00 |
| Buy Qty | 1.00 |
| Sell Price | 780.00 |
| Sell Qty | 6.00 |
9.25 am | 3 Oct 2018 | Business Standard
The acquisition of a majority stake in Bayshore will allow Ipca to commercialise its registered generic drug products in the US market
